Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: A Markov modelling analysis

Background:Primary aldosteronism affects 3-14% of hypertensive patients in the primary care setting and up to 30% in the hypertensive referral units. Although primary aldosteronism screening is recommended in patients with treatment-resistant hypertension, diagnosis at an earlier stage of disease ma...

Full description

Bibliographic Details
Main Authors: Woode, M.E., Wong, K., Reid, Christopher, Stowasser, M., Russell, G., Gwini, S., Young, M.J., Fuller, P.J., Yang, J., Chen, G.
Format: Journal Article
Language:English
Published: 2023
Subjects:
Online Access:http://purl.org/au-research/grants/nhmrc/1184927
http://hdl.handle.net/20.500.11937/93777